Puriblood Medical Co., Ltd. (6847) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Puriblood Medical Co., Ltd. (6847:TWSE), powered by AI.

Current Price
$76.60
Sector
Healthcare
What is the Puriblood Medical Co., Ltd. stock price forecast?

Puriblood Medical Co., Ltd. is currently trading at $76.60. View real-time AI analysis on Alpha Lenz.

What is Puriblood Medical Co., Ltd. insider trading activity?

View the latest insider trading data for Puriblood Medical Co., Ltd. on Alpha Lenz.

What is Puriblood Medical Co., Ltd.'s P/E ratio?

View Puriblood Medical Co., Ltd.'s valuation metrics on Alpha Lenz.

Puriblood Medical Co., Ltd.

TWSE · 6847
NT$76.60-1.40(-1.79%)
Ask about Puriblood Medical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Puriblood Medical Co., Ltd.'s ROE is -24.7%. Explore profitability and growth together.

Ask for details

Company Overview

Puriblood Medical Co., Ltd. is a healthcare company specializing in the development and production of advanced blood purification medical devices. Founded in 2015 and headquartered in Hsinchu, Taiwan, the company focuses on creating innovative solutions for both human and animal blood transfusion needs. Key products include leukocyte reduction filters, which are designed to remove white blood cells from blood products to minimize transfusion reactions in humans, as well as specialized filters and blood bags for veterinary applications. Puriblood Medical leverages proprietary membrane technologies and holds a significant portfolio of patents, including innovations such as its Zwitterionic-bias Surface Coating Technology, aimed at improving the safety and efficiency of blood cell separation. Through collaboration with clinicians and ongoing research, the company addresses critical demands in transfusion medicine and supports sectors including hospitals, laboratories, and animal health. Puriblood Medical Co., Ltd. plays a notable role in the medical diagnostics and research industry in Taiwan, contributing to improved clinical outcomes through enhanced blood filtration and purification solutions.

SectorHealthcare
IndustryDiagnostics & Research
Employees44

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$82.33MRevenue
0.00Shares Out
44Employees

Margins

39.24%Gross
-36.30%EBITDA
-40.61%Operating
-47.08%Pre-Tax
-47.37%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-15.70%Rev 3Yr
16.33%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-15.73%ROA
-24.72%ROE
-15.20%ROIC

Financial Health

NT$60.43MCash & Cash Equivalents
NT$36.04MNet Debt
68.80%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Puriblood Medical Co., Ltd. (ticker: 6847) is a company listed on TWSE in the Healthcare sector (Diagnostics & Research). It has approximately 44 employees.

The current price is 76.6 with a P/E ratio of -x and P/B of -x.

ROE is -24.72% and operating margin is -40.61%. Annual revenue is $82M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Puriblood Medical Co., Ltd. (6847) Stock Forecast 2026 $76.60 — Price, Financials & Analyst Targets | Alpha Lenz